Comparison of local tumor control in patients with HCC treated with SBRT or TACE: a propensity score analysis.

Dominic BettingerEleni GkikaMichael SchultheissNicolas GlaserSophie LangeLars MaruschkeNico BuettnerSimon KirsteUrsula NestleAnca-Ligia GrosuRobert ThimmeThomas B Brunner

Published in: BMC cancer (2018)

SBRT after prior HCC therapy in selected patients shows comparable LC at 1 year, OS and 1-year mortality compared to patients treated with TACE.

Keyphrases

radiation therapy
end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
prognostic factors
cardiovascular events
type diabetes
risk factors
data analysis